Accumulating clinical evidence demonstrates that GLP-1 receptor agonists can improve markers of fatty liver disease, though the strength of evidence varies by outcome measure and specific medication
[PubMed] [Google Scholar] 37.Sakaguchi S, Iizuka Y, Furusawa S, Tanaka Y, Takayanagi M, Takayanagi Y
Dharajiya N, Choudhury BK, Bacsi A, Boldogh I, Alam R, Sur S: Inhibiting pollen reduced nicotinamide adenine dinucleotide phosphate oxidase-induced signal by intrapulmonary administration of antioxidants blocks allergic airway inflammation
Performed correctly, it does not cause permanent scarring
10.1038/srep05896 93 ManczakM.ReddyP
The mechanism involves both direct structural protein synthesis and angiogenesis (new blood vessel formation), which is critical for delivering oxygen and nutrients to healing tissue